Clover Health is trading at $5.01, up +4.05%, after recent upside followed Deutsche Bank’s buy rating and $6 price target.
- No new company-specific announcement dated September 14, 2026, was identified in available coverage.
- The company is scheduled to present at the Jefferies Healthcare Services and Technology Conference on September 15.
- Broader indexes are lower, so today’s gain is not clearly explained by market direction.